NRX Pharmaceuticals Inc (NRXP) — Cash Flow Quality Index

Latest as of June 2020: -6.37x

NRX Pharmaceuticals Inc (NRXP) has a Cash Flow Quality Index of -6.37x as of June 2020. Operating cash flow of $-651.84K is below net income of $102.29K, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of NRX Pharmaceuticals Inc for the complete picture of this company's asset base.

Cash Flow Quality Index

-6.37x
Operating CF / Net Income

Operating Cash Flow

$-651.84K
USD

Net Income

$102.29K
USD

Data as of

Jun 2020
Most recent filing

NRX Pharmaceuticals Inc Cash Flow Quality Index (2018–2019)

Historical Cash Flow Quality Index for NRX Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NRXP intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for NRX Pharmaceuticals Inc (2018–2019)

Year-by-year earnings quality comparison for NRX Pharmaceuticals Inc. For live market cap and the full company financial profile, see NRX Pharmaceuticals Inc stock valuation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 -1.94x $-792.73K $408.43K ▲ +72.9%
2018 -7.16x $-473.19K $66.10K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.